首页> 美国卫生研究院文献>other >Composite sequential Monte Carlo test for post-market vaccine safety surveillance
【2h】

Composite sequential Monte Carlo test for post-market vaccine safety surveillance

机译:复合顺序蒙特卡洛检验用于上市后疫苗安全性监测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Group sequential hypothesis testing is now widely used to analyze prospective data. If Monte Carlo simulation is used to construct the signaling threshold, the challenge is how to manage the type I error probability for each one of the multiple tests without losing control on the overall significance level. This paper introduces a valid method for a true management of the alpha spending at each one of a sequence of Monte Carlo tests. The method also enables the use of a sequential simulation strategy for each Monte Carlo test, which is useful for saving computational execution time. Thus, the proposed procedure allows for sequential Monte Carlo test in sequential analysis, and this is the reason that it is called ‘composite sequential’ test. An upper bound for the potential power losses from the proposed method is deduced. The composite sequential design is illustrated through an application for post-market vaccine safety surveillance data.
机译:群体顺序假设检验现已广泛用于分析预期数据。如果使用蒙特卡洛模拟来构建信令阈值,那么面临的挑战是如何在不失去对总体显着性水平的控制的情况下,为多个测试中的每一个管理I型错误概率。本文介绍了一种有效管理蒙特卡洛测试序列中每个序列的alpha支出的有效方法。该方法还允许对每个蒙特卡洛测试使用顺序仿真策略,这对于节省计算执行时间很有用。因此,建议的程序允许在顺序分析中进行顺序蒙特卡洛检验,这就是将其称为“复合顺序”检验的原因。推导了所提出方法的潜在功率损耗的上限。通过上市后疫苗安全监视数据的应用程序说明了复合顺序设计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号